Taipei, Taiwan

Chiung-Tong Chen

This inventor holds 17 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: National Health Research Institutes, Academia Sinica, Development Center for Biotechnology. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chiung-Tong Chen. Retrieved from https://idiyas.com/inventor/chiung-tong-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 58.8

 

 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Zhunan, TW (2011 - 2016)
  • Taipei, TW (2005 - 2020)
  • Miaoli County, TW (2018 - 2024)

Company Filing History:


Years Active: 2005-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Neurotensin Antibodies
Pyrimidine Compounds
Heterocyclic Derivatives
Alzheimer's Disease
Pharmaceutical Uses
Indole Compounds
Imidazolamino
Imidazolidinone
Dipicolylamine
Formulations
Therapeutic Applications
17 patents (USPTO):Explore Patents

Title: The Innovations of Chiung-Tong Chen

Introduction

Chiung-Tong Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies and pharmaceutical compounds. With a total of 15 patents to his name, Chen's work has had a substantial impact on medical research and treatment methodologies.

Latest Patents

Among his latest patents is the development of humanized anti-human neurotensin receptor 1 antibodies and their uses. This patent includes a humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. It also outlines a method for treating, prophylactic treating, and/or preventing diseases and/or disorders caused by or related to NTSR1 activity and/or signaling, as well as a method or kit for detecting NTSR1 in a sample. Another notable patent involves poly heterocyclic conjugates and their pharmaceutical uses, which details compounds of Formula (I) and a pharmaceutical composition containing one of these compounds. This patent also discloses a method of treating conditions associated with uncontrolled cell growth using a compound of Formula (I).

Career Highlights

Chiung-Tong Chen has worked with esteemed organizations such as the National Health Research Institutes and the Development Center for Biotechnology. His career has been marked by a commitment to advancing medical science through innovative research and development.

Collaborations

Throughout his career, Chen has collaborated with notable colleagues, including Der-Ren Hwang and Wen-Tai Li. These partnerships have further enhanced the scope and impact of his research.

Conclusion

Chiung-Tong Chen's contributions to biotechnology and his extensive patent portfolio underscore his role as a leading inventor in the field. His innovative work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…